CompletedPhase 4ketamine

Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Ketamine

Sponsored by University of Texas Southwestern Medical Center

NCT ID
NCT03621085
Target Enrollment
43 participants
Start Date
2018-06-01
Est. Completion
2021-06-30

About This Study

The purpose of this project is to test how ketamine, an analgesics currently employed in the pre-hospital setting by the US Army, alters the capacity to tolerate a hemorrhagic insult in humans.

Conditions Studied

HemorrhageHealthy

Interventions

  • Ketamine Hydrochloride
  • Placebo

Eligibility

Age:18 Years - 45 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

* 18-45 years of age
* Healthy
* Non-obese (body mass index less than 30 kg/m2)
* Body mass greater than or equal to 65 kg

Exclusion Criteria:

* Subjects not in the defined age range
* Subjects who have cardiac, respiratory, neurological and/or metabolic illnesses
* Any known history of renal or hepatic insufficiency/disease
* Pregnancy or breast feeding
* Body mass less than 65 kg
* Current smokers, as well as individuals who regularly smoked within the past 3 years
* Positive urine drug screen
* Currently taking pain modifying medication(s)

Study Locations (1)

Texas Health Presbyterian Hospital Dallas
Dallas, Texas, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source